Cochrane · systematic review · CD008554
Repetitive transcranial magnetic stimulation for the treatment of amyotrophic lateral sclerosis or motor neuron disease
Fang, J, Zhou, M, Yang, M, et al. · Cochrane Database of Systematic Reviews · 2013 · Cochrane Library
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
2
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 2 · 50%Very low 0 · 0%Low 2 · 50%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Show all 2 versionsrTMS compared to sham rTMS for the treatment of amyotrophic lateral sclerosis or motor neuron disease
Population: patients with the treatment of amyotrophic lateral sclerosis or motor neuron disease
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Changes to the ALSFRS‐R scores at 12 months rTMS vs sham rTMS | no estimate extracted | 1 study · 12 participants | Low Downgraded: risk of bias |
Changes to the MMT scores at 12 months rTMS vs sham rTMS | no estimate extracted | 1 study · 12 participants | Low Downgraded: risk of bias |
Changes to FSS at 12 months rTMS vs sham rTMS | no estimate extracted | 0 studies · 0 participants | Ungraded |
Adverse events leading to cessation of treatment rTMS vs sham rTMS | no estimate extracted | 3 studies · 50 participants | Ungraded |